BioCentury
ARTICLE | Company News

Indevus, Esprit sales and marketing update

July 18, 2005 7:00 AM UTC

The companies completed their previously announced deal for Esprit to co-promote IDEV's Sanctura trospium chloride to treat overactive bladder in the U.S. IDEV and Esprit (formerly Saturn Pharmaceuti...